Accelrys Narrows Net Loss in Fiscal Q1 Though Revenues Inch Down | GenomeWeb
NEW YORK (GenomeWeb News) – Accelrys reported its fiscal year 2007 first quarter results today and said its net loss shrank 83 percent.
 
Receipts for the three months ended June 30 inched down to $20.1 million, from $20.4 million year over year. The company said the decline is the result of fluctuations in foreign currency exchange rates.
 
Product development costs also declined 12 percent, to $5.1 million from $5.8 million from the comparable quarter a year ago.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.